Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/28/2012CN102803232A Antifungal 1, 2, 4-triazolyl Derivatives Having A 5- Sulfur Substituent
11/28/2012CN102803231A Antifungal 1,2,4-triazolyl derivatives
11/28/2012CN102803230A Antifungal 1,2,4-triazolyl derivatives having a 5-sulfur substituent
11/28/2012CN102803228A Acid-labile trigger units
11/28/2012CN102803227A Morpholinylquinazolines
11/28/2012CN102803226A Cycloalkyl-substituted imidazole derivative
11/28/2012CN102803225A Imidazole derivatives and their use as modulators of cyclin dependent kinases
11/28/2012CN102803224A Novel azabicyclohexanes
11/28/2012CN102803223A Cyclic compound having substituted phenyl group
11/28/2012CN102803217A Aryl pyridine as aldosterone synthase inhibitors
11/28/2012CN102803216A Heterocyclic antiviral compounds
11/28/2012CN102803214A New compounds, pharmaceutical composition and methods relating thereto
11/28/2012CN102803212A Heterocyclic Antiviral Compound
11/28/2012CN102803211A High penetration compositions or prodrugs of antimicrobials and antimicrobial-related compounds
11/28/2012CN102803210A Azetidinyl diamides as monoacylglycerol lipase inhibitors
11/28/2012CN102803204A Cycloalkylcarbamate benzamide aniline HDAC inhibitor compounds
11/28/2012CN102803199A Novel acetylsalicylic acid salts
11/28/2012CN102802731A Benzimidazole derivatives useful as TRPM8 channel modulators
11/28/2012CN102802730A Benzimidazole derivatives useful as TRPM8 channel modulators
11/28/2012CN102802729A Liquid dosage forms of isotretinoin
11/28/2012CN102802670A Stabilized proteases for use in skin care
11/28/2012CN102802668A Stabilised composition comprising at least one adrenergic compound
11/28/2012CN102802665A Influenza vaccine, composition, and methods of use
11/28/2012CN102802647A Bacteria thyA(-) mutants with increased vitamin K
11/28/2012CN102802644A Mixtures of acids for use as antiviral agents
11/28/2012CN102802640A Methods of analyzing peptide mixtures
11/28/2012CN102802639A Lipopolysaccharide of ochrobactrum intermedium and their use as immunostimulant of mammalians
11/28/2012CN102802638A Glycosaminoglycan mixtures
11/28/2012CN102802637A New potent anti APOB antisense compounds
11/28/2012CN102802636A Hydrolysate of crocin
11/28/2012CN102802635A Anaesthetic formulation
11/28/2012CN102802634A 17[beta]-alkyl-17[alpha]-oxy-estratrienes
11/28/2012CN102802633A Method for improving bioavailability of latanoprost
11/28/2012CN102802632A Pharmaceutical composition comprising a pyrimidineone derivative
11/28/2012CN102802631A Dosing regimen associated with long-acting injectable paliperidone esters
11/28/2012CN102802630A Reversal of l-dopa-induced dyskinesia by neuronal nicotinic receptor ligands
11/28/2012CN102802629A Substituted 4-hydroxypyrimidine-5-carboxamides
11/28/2012CN102802628A Substituted 4-hydroxypyrimidine-5-carboxamides
11/28/2012CN102802627A Voltage-gated sodium channel blockers
11/28/2012CN102802626A Niacin and/or trigonelline as a muscle stimulant
11/28/2012CN102802625A Therapeutic combinations of theobromine and an antihistamine
11/28/2012CN102802624A Nanodispersion Of A Drug And Process For Its Preparation
11/28/2012CN102802623A Compounds, compositions and methods comprising 1,3,4-oxadiazole derivatives
11/28/2012CN102802622A Compositions and methods for treating ischemia and ischemia-reperfusion injury
11/28/2012CN102802621A Methods and compositions for increasing trichogenic potency of dermal cells
11/28/2012CN102802620A Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors
11/28/2012CN102802619A Ophthalmic composition
11/28/2012CN102802618A Therapeutic Combinations Of Nicotinic Acid And Meldonium
11/28/2012CN102802616A Polyarginine Nanocapsules
11/28/2012CN102802615A Novel composition
11/28/2012CN102802613A Sodium Ibuprofen Tablets And Methods Of Manufacturing Pharmaceutical Compositions Including Sodium Ibuprofen
11/28/2012CN102802612A Solid compositions comprising 5-aminolevulinic acid
11/28/2012CN102802611A Pharmaceutical composition containing carboxylosartan and a production method therefor
11/28/2012CN102802610A Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same
11/28/2012CN102802609A Stable nanoparticulate drug suspension
11/28/2012CN102802608A Dosage forms of apixaban
11/28/2012CN102802607A Solid dispersions containing an apoptosis-promoting agent
11/28/2012CN102802606A Pharmaceutical dosage form for oral administration of a BCL-2 family inhibitor
11/28/2012CN102802605A Stabilized lipid formulation of apoptosis promoter
11/28/2012CN102802604A Aqueous pharmaceutical compositions containing borate-polyol complexes
11/28/2012CN102802442A Prenatal milk-derived composition for preventing the risk of low birthweight of newborns
11/28/2012CN102802438A Method for reducing unpleasant taste
11/28/2012CN102802428A Copepod oil composition, formulations comprising the oil composition, and the use thereof to reduce accumulation of visceral fat, improve glucose tolerance, and prevent or treat obesity related diseases and disorders
11/28/2012CN102802420A Method Of Treating Hepatocellular Carcinoma
11/28/2012CN102802419A HEDGEHOG inhibitors
11/28/2012CN102802418A Compositions and methods for treating amyotrophic lateral sclerosis
11/28/2012CN102802415A Treatment Of Multiple Sclerosis With Laquinimod
11/28/2012CN102802414A Ectoparasiticidal methods and formulations
11/28/2012CN102796254A Pegylated celastrol and preparation method and application thereof
11/28/2012CN102796235A Copolymer based on environmental response and preparation method thereof
11/28/2012CN102796166A Glucose-modified 4H-beta-carboline carboxylic acid derivative and preparation method and application thereof
11/28/2012CN102796161A Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors
11/28/2012CN102796160A 17ss-hsd1 and sts inhibitors
11/28/2012CN102796159A Dammarane glucosides and preparation method and application thereof
11/28/2012CN102796157A Caudatin derivative and medicinal composition and application thereof
11/28/2012CN102796156A Adenosine cyclophosphate double-molecule meglumine compound and preparation method thereof
11/28/2012CN102796155A Nucleotide and oligonucleotide prodrugs
11/28/2012CN102796153A Novel antitumor component Swertiridoid A in swertia phragmitiphylla
11/28/2012CN102796140A Phosphate-containing isoxazoline derivatives and their preparation method and use
11/28/2012CN102796139A Phosphoramido pyridine derivative, and preparation method, medical composition and application thereof in antifungal agent
11/28/2012CN102796138A (2-(3-methylthio-1,2,4-thiadiazinyl)ethyoxyl)methyl phosphonate derivatives, and preparation and application thereof
11/28/2012CN102796124A Di-beta-carboline alkali compound and preparation method, medicinal composition and application thereof
11/28/2012CN102796121A 3-aryl-7H-thiazol[3,2-b]-1,2,4-triazinyl-7-one derivatives and application thereof
11/28/2012CN102796119A Cefpirome sulfate compound and composition thereof
11/28/2012CN102796118A Cefodizime sodium compound solid, method for preparing same and pharmaceutical preparation of cefodizime sodium compound solid
11/28/2012CN102796113A Xanthone compound, and preparation method and application thereof
11/28/2012CN102796112A Prenylflavonoid compound and application thereof in preparation of pancrelipase inhibitor
11/28/2012CN102796110A Aniline pyrimidine compound and preparation method and application thereof
11/28/2012CN102796109A 4-aminoquinazoline compound and preparation method and application thereof
11/28/2012CN102796103A 6-(aryl formyl) imidazo [1,2-a] pyrimidine and 6-(aryl formyl) [1,2,4] triazol [4,3-a] pyrimidine serving as Hedgehog inhibitors and application thereof
11/28/2012CN102796100A Substituted phenyl-(diazaspiro-N)-ketone derivative
11/28/2012CN102796099A Imidazoquinolines as lipid kinase inhibitors
11/28/2012CN102796098A (1S, 3S)-1-1, 3-benzodioxole-1, 2, 3, 4-tetrahydrophthalic anhydride-beta-carboline-3-formyl-amino acid methyl ester, and preparation method and application thereof
11/28/2012CN102796097A Phenanthroindolizidine alkaloid derivative, and preparation method, medical composition and application thereof
11/28/2012CN102796096A Hexahydro dibenzo [a,g] quinolizidine compound and preparation method, medicinal composition and application thereof
11/28/2012CN102796095A Tetrahydroquinoline analogues as muscarinic agonists
11/28/2012CN102796093A Thiomorpholine-containing pyrrole derivatives and their preparation method and use
11/28/2012CN102796092A Oxazolidinone derivative, and preparation method and application thereof
11/28/2012CN102796091A Substituted oxazolidinone compound and preparation method and application thereof
11/28/2012CN102796087A Coumarin triadimenol, and preparation method and application thereof
1 ... 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 ... 7860